Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/74741
- Title:
- Estudo duplo cego com Isoconazol e Terbinafina tópicos no tratamento de um paciente com Tinea nigra plantaris bilateral e sugestões para novos diagnósticos diferenciais
- Double-blind study with topical isoconazole and terbinafine for the treatment of one patient with bilateral Tinea nigra plantaris and suggestions for new differential diagnosis
- University of Vale
- Pharmaceuticals-Biochemistry from the University of Vale
- Universidade Estadual Paulista (UNESP)
- 0036-4665
- 1678-9946
- The authors report a case of bilateral Tinea nigra plantaris treated through a double-blind study with the topical antifungal agents Isoconazole and Terbinafine. The objective of the study was to clinically compare the efficacy of these two topical antifungal agents on days 10, 20 and 30 of the treatment. No significant clinical differences were found, as all the plantar lesions regressed completely by the end of the treatment. Our conclusion was that in the case reported, the topical antifungal agents Isoconazole and Terbinafine demonstrated identical efficacy as a clinical cure. We also suggest the inclusion of injuries caused by arthropods of the Diplopoda Class in the differential diagnosis of Tinea nigra plantaris, due to the persistent acral hyperpigmentation.
- 1-Mar-2013
- Revista do Instituto de Medicina Tropical de Sao Paulo, v. 55, n. 2, p. 125-128, 2013.
- 125-128
- Antifungal agents
- Dermatomycoses
- Mycoses
- Tinea
- isoconazole
- terbinafine
- adult
- case report
- controlled clinical trial
- controlled study
- differential diagnosis
- double blind procedure
- drug efficacy
- human
- hyperpigmentation
- insect bite
- male
- millipede
- nonhuman
- tinea nigra
- tinea nigra plantaris
- http://dx.doi.org/10.1590/S0036-46652013000200011
- Acesso aberto
- outro
- http://repositorio.unesp.br/handle/11449/74741
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.